Amgen, Inc. (#AMGN) Stock Price, Live Chart & Analysis | Trade #AMGN

Amgen specializes in human therapeutics. There are six major areas it focuses on: cardiovascular disease, inflammation, oncology/hematology, nephrology, neuroscience, and bone health. Amgen is famous for the discovery and development of the most successful drugs in biotech history.

The company (originally AMGen, which stood for Applied Molecular Genetics) was founded in Thousand Oaks, California, in April 1980. In June 1983, the company held an IPO, raising around $40 million. That year, the company officially changed its name. Institutional investors own over 70% of the company’s shares. It’s much higher than at most firms in the biotechnology industry.

Amgen pays dividends. They have been stable for a decade. However, they are lower than the US drug manufacturers industry and US market average. Moreover, AMGN stock price changes its direction constantly. That’s why CFD trading is a better option for those who would like to deal with Amgen’s shares.

The company has been existing for years, so it isn’t surprising that it has faced numerous lawsuits. The most outstanding one occurred in 2012. Amgen paid $762 million in criminal penalties and liabilities for unlawful promotion, misleading marketing, including off-label advertising and kickbacks to healthcare providers, and false price reporting. Thus, traders should check the news frequently to be sure the company is not involved in any conflict.

According to analysts, the company generates the most significant positive value in the physical illness, tax, and job categories. Amgen has the largest impact on the physical diseases category via its products. However, it may negatively affect such categories as scarce human capital and GHG emissions.

Amgen’s revenue and earnings growth are much lower than the US drug manufacturers industry and US market average. The company’s financial data have been changing year to year. At the same time, the company’s return on equity metric says the company is quite stable, which reflects a durable competitive advantage.